
1. j clin invest. 2012 oct;122(10):3618-28. doi: 10.1172/jci62684. epub 2012 sep 10.

complete plasmodium falciparum liver-stage development liver-chimeric mice.

vaughan am(1), mikolajczak sa, wilson em, grompe m, kaushansky a, camargo n, bial
j, ploss a, kappe sh.

author information: 
(1)seattle biomedical research institute, seattle, washington 98109, usa.

plasmodium falciparum, causes lethal form human malaria,
replicates host liver initial stage infection. however, in
vivo malaria liver-stage (ls) studies humans virtually impossible, 
vitro models ls development reconstitute relevant parasite growth
conditions. overcome obstacles, adopted robust mouse model for
the study p. falciparum ls vivo: immunocompromised and
fumarylacetoacetate hydrolase-deficient mouse (fah-/-, rag2-/-, il2rg-/-, termed 
the frg mouse) engrafted human hepatocytes (frg huhep). frg huhep mice
supported vigorous, quantifiable p. falciparum ls development culminated 
complete maturation ls approximately 7 days infection, providing a
relevant model ls development humans. infections allowed observations 
of previously unknown expression proteins ls, including p. falciparum
translocon exported proteins 150 (ptex150) exported protein-2 (exp-2),
components known parasite protein export machinery. ls schizonts exhibited
exoerythrocytic merozoite formation merosome release. furthermore, frg mice
backcrossed nod background repopulated huheps human red blood
cells supported reproducible transition ls infection blood-stage
infection. thus, mice constitute reliable models study human ls directly
in vivo demonstrate utility studies ls-to-blood-stage transition 
human malaria parasite.

doi: 10.1172/jci62684 
pmcid: pmc3461911
pmid: 22996664  [indexed medline]

